Gfi-1 Monoclonal Antibody

This gene encodes a nuclear zinc finger protein that functions as a transcriptional repressor. This protein plays a role in diverse developmental contexts, including hematopoiesis and oncogenesis. It functions as part of a complex along with other cofactors to control histone modifications that lead to silencing of the target gene promoters. Mutations in this gene cause autosomal dominant severe congenital neutropenia, and also dominant nonimmune chronic idiopathic neutropenia of adults, which are heterogeneous hematopoietic disorders that cause predispositions to leukemias and infections. Multiple alternatively spliced variants, encoding the same protein, have been identified for this gene.

Introducing the GFI-1 Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of immunology. This meticulously crafted product showcases exceptional quality and unrivaled efficacy, making it an indispensable tool for researchers and scientists alike.

The GFI-1 Monoclonal Antibody is meticulously engineered using state-of-the-art techniques, ensuring its exceptional specificity and affinity towards its target antigen. This antibody exhibits remarkable binding capabilities, enabling precise and accurate detection of the desired protein, thus facilitating a deeper understanding of cellular processes and molecular interactions.

With its superior performance, the GFI-1 Monoclonal Antibody offers an unparalleled advantage in various applications, including immunohistochemistry, flow cytometry, and western blotting. Its exceptional sensitivity and reliability empower researchers to obtain reliable and reproducible results, facilitating groundbreaking discoveries and advancements in the field of immunology.

Furthermore, the GFI-1 Monoclonal Antibody boasts exceptional versatility, making it compatible with a wide range of sample types and species. This adaptability ensures its seamless integration into diverse experimental setups, catering to the unique requirements of researchers across different disciplines.

In addition to its exceptional performance, the GFI-1 Monoclonal Antibody is manufactured under stringent quality control measures, guaranteeing its consistency and reliability. Each batch undergoes rigorous testing to ensure its purity, potency, and stability, thereby instilling confidence in its users and ensuring optimal experimental outcomes.

The GFI-1 Monoclonal Antibody represents a breakthrough in immunological research, offering an indispensable tool for scientists and researchers striving to unravel the complexities of the immune system. With its exceptional quality, unrivaled efficacy, and meticulous manufacturing process, this product stands at the forefront of innovation, empowering researchers to push the boundaries of scientific knowledge and pave the way for groundbreaking discoveries.